Market Tracker

12/19 3:57pm ET
216.94
Real-Time Quote
 -3.94 / -1.78%
Today’s Change
136.68
Today|||52-Week Range
264.98
+53.54%
Year-to-Date

Today’s Trading

Previous close220.88
Today’s open216.46
Day’s range215.44 - 218.87
Volume770,355
Average volume (3 months)1,984,637
Market cap$43.4B
Dividend yield0.29%
Data as of 3:42pm ET, 12/19/2014

Growth & Valuation

Earnings growth (last year)-10.64%
Earnings growth (this year)--
Earnings growth (next 5 years)+16.33%
Revenue growth (last year)+4.91%
P/E ratioNM
Price/Sales5.28
Price/Book8.01

Competitors

 Today’s
change
Today’s
% change
VRXValeant Pharmaceutic...+3.06+2.14%
ALXNAlexion Pharmaceutic...+0.66+0.35%
VRTXVertex Pharmaceutica...+2.65+2.25%
AGNAllergan+0.98+0.46%
Data as of 3:57pm ET, 12/19/2014

Financials

Next reporting dateFebruary 12, 2015
EPS forecast (this quarter)$2.60
Annual revenue (last year)$4.9B
Annual profit (last year)$663.2M
Net profit margin28.77%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
Flemming ├śrnskov
Chief Financial Officer, Senior VP &
Controller
James Bowling
Corporate headquarters
Dublin, --

Forecasts